Telangana: 3 kg of Ephedrine worth Rs 60 lakh seized, 2 held

Written By :  Ruchika Sharma
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-08-13 06:00 GMT   |   Update On 2024-08-13 06:00 GMT

Hyderabad: In a significant operation, the Directorate of Revenue Intelligence (DRI) Hyderabad Zonal Unit (HZU) has arrested two individuals and confiscated 3 kilograms of Ephedrine/Pseudoephedrine, with a value of Rs 60 lakh in the grey market.

The arrests came after DRI officers, acting on specific intelligence, intercepted the suspects on Friday in Hyderabad. The individuals were found attempting to courier a package destined for New Zealand. A meticulous examination led to the discovery of two vacuum-sealed transparent packets, according to a DRI statement issued on Saturday.

Advertisement
As per the UNI report, A white powdery substance found in both packets tested positive for Ephedrine/Pseudoephedrine using a field test kit. The 3 kg of Ephedrine/Pseudoephedrine, valued at Rs 60 lakh in the illicit market, was seized, and the two individuals were arrested under the provisions of the NDPS Act, 1985.
Ephedrine and Pseudoephedrine are classified as controlled substances under the Narcotic Drugs and Psychotropic Substances (NDPS) Act. These chemicals are precursors for the illicit manufacture of amphetamine and methamphetamine, collectively known as Amphetamine-Type Stimulants (ATS).
Further investigation is ongoing., the statement added.

Read also: Ephedrine effective for correction of hypotension during GA, even in elderly patients

Medical Dialogues team had earlier reported that the Gujarat Anti-Terrorist Squad (ATS) raided a mephedrone manufacturing unit in Thane district of neighbouring Maharashtra, seizing liquid drug valued at Rs 800 crore.

Read also: Liquid drugs worth Rs 831 crore seized from Thane, Bharuch

Tags:    
Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News